Sign in

CIK 0001075880 · Non-accelerated filer

KAZIA THERAPEUTICS LTD

Sign in to watch
Ticker
KZIA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
Australia
Entity type
operating
Phone
01161298780088
Business address
THREE INTERNATIONAL TOWERS LEVEL 24,, 300 BARANGAROO AVENUE, SYDNEY NSW, Australia, 2000
Former names
NOVOGEN LTD
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 6-K Event Report of Foreign Issuer
  4. EFFECT Other Notice of Effectiveness
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. UPLOAD Other SEC-generated Letter
  7. 424B3 Offering Prospectus
  8. 424B3 Offering Prospectus
  9. 424B3 Offering Prospectus
  10. 424B3 Offering Prospectus
  11. 6-K Event Report of Foreign Issuer
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. F-3 Offering F-3
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. SCHEDULE 13G Stake Statement of Beneficial Ownership
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 5 of 60 · 1,191 filings